DASATINIB DR.REDDY'S dasatinib 70 mg film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

dasatinib dr.reddy's dasatinib 70 mg film coated tablet blister pack

dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 81.2 mg (equivalent: dasatinib, qty 70 mg) - tablet, film coated - excipient ingredients: silicon dioxide; croscarmellose sodium; magnesium stearate; triacetin; titanium dioxide; microcrystalline cellulose; lactose; hydrogenated castor oil; hypromellose - dasatinib dr.reddy's is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib. ? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib dr.reddy's is indicated for the treatment of paediatric patients with: ? ph+ cml in the chronic phase. ? newly diagnosed ph+ all in combination with chemotherapy.

DASATINIB-DRLA dasatinib 70 mg film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

dasatinib-drla dasatinib 70 mg film coated tablet blister pack

dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 81.2 mg (equivalent: dasatinib, qty 70 mg) - tablet, film coated - excipient ingredients: hydrogenated castor oil; triacetin; lactose; hypromellose; microcrystalline cellulose; magnesium stearate; titanium dioxide; silicon dioxide; croscarmellose sodium - dasatinib-drla is indicated for the treatment of adults aged 18 years or over with:,- newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. - philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib-drla is indicated for the treatment of paediatric patients with:,- newly diagnosed ph+ all in combination with chemotherapy.

DASACEL 70 mg dasatinib 70 mg film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

dasacel 70 mg dasatinib 70 mg film coated tablet blister pack

dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 81.2 mg (equivalent: dasatinib, qty 70 mg) - tablet, film coated - excipient ingredients: lactose; magnesium stearate; triacetin; titanium dioxide; microcrystalline cellulose; hypromellose; hydrogenated castor oil; croscarmellose sodium; silicon dioxide - dasatinib-rz is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib. ? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib-rz is indicated for the treatment of paediatric patients with: ? ph+ cml in the chronic phase. ? newly diagnosed ph+ all in combination with chemotherapy.

REDDY'S-DASATINIB dasatinib 70 mg film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

reddy's-dasatinib dasatinib 70 mg film coated tablet blister pack

dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 81.2 mg (equivalent: dasatinib, qty 70 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; silicon dioxide; croscarmellose sodium; titanium dioxide; hypromellose; lactose; magnesium stearate; triacetin; hydrogenated castor oil - reddy's-dasatinib is indicated for the treatment of adults aged 18 years or over with:,- newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. - philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,reddy's-dasatinib is indicated for the treatment of paediatric patients with:,- newly diagnosed ph+ all in combination with chemotherapy.

DASATINIB TARO 100 MG Israel - English - Ministry of Health

dasatinib taro 100 mg

taro international ltd, israel - dasatinib - film coated tablets - dasatinib 100 mg - dasatinib - dasatinib taro is indicated for the treatment of adult patients with: * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.

DASATINIB TARO 140 MG Israel - English - Ministry of Health

dasatinib taro 140 mg

taro international ltd, israel - dasatinib - film coated tablets - dasatinib 140 mg - dasatinib - dasatinib taro is indicated for the treatment of adult patients with: * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.

DASATINIB TARO 20 MG Israel - English - Ministry of Health

dasatinib taro 20 mg

taro international ltd, israel - dasatinib - film coated tablets - dasatinib 20 mg - dasatinib - dasatinib taro is indicated for the treatment of adult patients with: * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.

DASATINIB TARO 50 MG Israel - English - Ministry of Health

dasatinib taro 50 mg

taro international ltd, israel - dasatinib - film coated tablets - dasatinib 50 mg - dasatinib - dasatinib taro is indicated for the treatment of adult patients with: * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.

DASATINIB TARO 70 MG Israel - English - Ministry of Health

dasatinib taro 70 mg

taro international ltd, israel - dasatinib - film coated tablets - dasatinib 70 mg - dasatinib - dasatinib taro is indicated for the treatment of adult patients with: * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.

DASATINIB TARO 80 MG Israel - English - Ministry of Health

dasatinib taro 80 mg

taro international ltd, israel - dasatinib - film coated tablets - dasatinib 80 mg - dasatinib - dasatinib taro is indicated for the treatment of adult patients with:* newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.